Funded Projects › HORIZON
NOVA · Next Generation BiOactiVe NAnocoatings
NOVA aims to provide a comprehensive approach to antimicrobial coating development by creating an effective feedback loop between coating design, end use and functional/safety testing. This consists of combinatorial optimisation of 4 coating technologies: i) light activated based on: UV up-converters, nanoscale photocatalysts and hydrophobic carbon-based Quantum Dots and ii) contact killing biopolymers (chain-length controlled supramolecular assemblies of polypeptides and polysaccharides). The coatings will be adjusted in a use case driven specifications for having the capacity to coat different substrates in the same environment such as hospitals. In order to guarantee safety for citizens and environment, the coatings will be developed with a Safe and Sustainable by Design (SSbD) approach taking into account the environmental risks. NOVA will develop advanced tissue tests and immunotoxicity tests optimized for coatings to provide tools for the regulatory bodies an in depth analysis of future coatings. For demonstrating practical efficacy, real-life mimicking, innovative antimicrobial tests will be developed. The validated coatings will be developed for commercial exploitation by upscaling using the capacities of the industrial partners. For easier adoption specific coating application devices will be designed within the project. Finally, the experimental data generated within the project together with the historical data of coating developers of the consortium will be used for developing predictive models using machine learning methodologies for expedited coating development methodologies in the future. NOVA aims to bring high efficiency, eco-friendly, stable coatings demonstrated within the project in 4 main use cases (textiles, paints, tactile electronics and frequently touched hard surfaces with high hygienical relevance like e.g. in hospitals and common hygienical relevance in public spaces) which can be then expanded for more widespread utilization.
Consortium · 16 organisations
DECHEMA GESELLSCHAFT FUR CHEMISCHETECHNIK UND BIOTECHNOLOGIE
DE · €555,451
SIEMENS HEALTHINEERS AG
DE · €46,861
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €360,823
AKZO NOBEL DECORATIVE COATINGS BV
NL · €136,250
PRESTE LIMITED LIABILITY COMPANY
UA
FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
DE · €946,703
THE MANCHESTER METROPOLITAN UNIVERSITY
UK
INDUSTRIAL MICROBIOLOGICAL SERVICES LIMITED
UK
USTAV POLYMEROV SLOVENSKEJ AKADEMIEVIED VEREJNA VYSKUMNA INSTITUCIA
SK · €255,300
DOLMEN DESIGN AND INNOVATION LIMITED
IE · €527,122
SIEMENS HEALTHCARE GMBH
DE · €13,139
SPARTHA MEDICAL
FR · €652,650
EVONIK OPERATIONS GMBH
DE · €640,757
EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT
CH
PRESTE
FR · €366,125
UNIVERZA V LJUBLJANI
SI · €197,887
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.